{"id":"NCT00662909","sponsor":"Astellas Pharma Inc","briefTitle":"A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder","officialTitle":"A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-03-28","primaryCompletion":"2009-04-22","completion":"2009-04-22","firstPosted":"2008-04-21","resultsPosted":"2012-10-17","lastUpdate":"2024-11-20"},"enrollment":2149,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Urinary Bladder, Overactive"],"interventions":[{"type":"DRUG","name":"Mirabegron","otherNames":["YM178","Myrebtriq"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Mirabegron 50 mg","type":"EXPERIMENTAL"},{"label":"Mirabegron 100 mg","type":"EXPERIMENTAL"}],"summary":"The study is intended to test the efficacy, safety and tolerability of two doses of mirabegron against placebo to treat patients with symptoms of overactive bladder","primaryOutcome":{"measure":"Change From Baseline to End of Treatment (Final Visit) in Mean Number of Incontinence Episodes Per 24 Hours","timeFrame":"Baseline and Week 12 (Final Visit)","effectByArm":[{"arm":"Placebo","deltaMin":-1.13,"sd":0.112},{"arm":"Mirabegron 50 mg","deltaMin":-1.47,"sd":0.114},{"arm":"Mirabegron 100 mg","deltaMin":-1.63,"sd":0.117}],"pValues":[{"comp":"OG000 vs OG001","p":"0.026"},{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":12},"locations":{"siteCount":125,"countries":["United States","Canada"]},"refs":{"pmids":["23079373","24246044"],"seeAlso":["https://www.astellasclinicalstudyresults.com/study.aspx?ID=36"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":453},"commonTop":["Hypertension"]}}